New Thalassemia Study Findings Have Been Reported by Researchers at Second Xiangya Hospital (Preliminary screening of biomarkers and drug candidates in a mouse model of b-thalassemia based on quasi-targeted metabolomics).

The article discusses new research from Second Xiangya Hospital on beta-thalassemia, using quasi-targeted metabolomics to identify biomarkers and potential drug candidates in a mouse model. Topics include metabolic disorders related to beta-thalassemia, key metabolites for predicting the disease, and potential drug candidates based on molecular docking studies.